FGF23 and plasma cell myeloma: Our results suggest that FGF23 from skeletal osteocytes drives a vicious cycle [50] of myeloma growth in bone by binding to MM cells and activating transcription of pro-metastatic and pro-osteolytic genes, such as heparanase.